Consultant Physician
Department of Medical Oncology, National Cancer Center Hospital, Japan
Yasuhiro Fujiwara, MD, PhD is Chief Executive of Pharmaceutical Medical Devices Agency (PMDA), Tokyo, Japan and Consultant Physician at Department of Medical Oncology of National Cancer Center Hospital. Before leading PMDA, he was Director-General, Strategic Planning Bureau of the National Cancer Center, and the Deputy Director of the Hospital, National Cancer Center Hospital. He was also a staff scientist at National Cancer Center Research Institute, and was an assistant professor of internal medicine at Hiroshima University School of Medicine.
Between Jan 2011 to Feb 2013, he was a Deputy Secretary General of Office of Medical Innovation, Cabinet Secretariat of Japan
Educational background:
MD from Hiroshima University School of Medicine, 1984
PhD from Hiroshima University, 1991
Internal Medicine Residency at Kure Kyosai Hospital 1984-1986
Oncology Fellow at NCCH 1986-1989
UICC Fellow, University of Chicago and Johns Hopkins Oncology Center 1994
JSPS Fellow, University of Maryland Cancer Center 1996-1997
Speciality and Research Field of Interest:
Medical oncology, specifically systemic therapy for breast cancer
Molecular and Clinical pharmacological mechanism of drug resistance
Health Policy and Regulatory Science for drug development
Academic activity:
Dr Fujiwara has authored or co-authored over 280 articles in peer-reviewed journals including Nature Reviews Drug Discovery, Lancet, Lancet Oncology, Journal of Clinical Oncology, Cancer Research and Annals of Oncology. He is an active member of American Society of Clinical Oncology (between 2003 and 2006, he was International Affairs Committee’s member), an active member of American Association for Cancer Research and Board Member of Japanese Society of Medical Oncology (JSMO) (He will be the President of 2019 JSMO annual meeting, held in Kyoto) . He is on the Editorial Board of Cancer Chemotherapy and Pharmacology; Asian-Pacific Journal of Clinical Oncology; Japanese Journal of Clinical Oncology, and Cancer Science.